- Home
- CNFR vs HOTH Comparison
CNFR vs HOTH Comparison
Compare CNFR & HOTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CNFR
- HOTH
- Stock Information
- Founded
- CNFR 2009
- HOTH 2017
- Country
- CNFR United States
- HOTH United States
- Employees
- CNFR N/A
- HOTH N/A
- Industry
- CNFR Property-Casualty Insurers
- HOTH Biotechnology: Pharmaceutical Preparations
- Sector
- CNFR Finance
- HOTH Health Care
- Exchange
- CNFR Nasdaq
- HOTH Nasdaq
- Market Cap
- CNFR 8.3M
- HOTH 8.3M
- IPO Year
- CNFR 2015
- HOTH 2019
- Fundamental
- Price
- CNFR $0.65
- HOTH $0.86
- Analyst Decision
- CNFR
- HOTH Strong Buy
- Analyst Count
- CNFR 0
- HOTH 3
- Target Price
- CNFR N/A
- HOTH $4.00
- AVG Volume (30 Days)
- CNFR 42.9K
- HOTH 626.4K
- Earning Date
- CNFR 05-13-2025
- HOTH 05-13-2025
- Dividend Yield
- CNFR N/A
- HOTH N/A
- EPS Growth
- CNFR N/A
- HOTH N/A
- EPS
- CNFR 1.92
- HOTH N/A
- Revenue
- CNFR $66,771,000.00
- HOTH N/A
- Revenue This Year
- CNFR $25.91
- HOTH N/A
- Revenue Next Year
- CNFR N/A
- HOTH N/A
- P/E Ratio
- CNFR $0.34
- HOTH N/A
- Revenue Growth
- CNFR N/A
- HOTH N/A
- 52 Week Low
- CNFR $0.42
- HOTH $0.58
- 52 Week High
- CNFR $1.91
- HOTH $3.80
- Technical
- Relative Strength Index (RSI)
- CNFR 48.74
- HOTH 46.39
- Support Level
- CNFR $0.60
- HOTH $0.74
- Resistance Level
- CNFR $0.68
- HOTH $0.87
- Average True Range (ATR)
- CNFR 0.07
- HOTH 0.08
- MACD
- CNFR 0.02
- HOTH 0.01
- Stochastic Oscillator
- CNFR 78.23
- HOTH 93.30
About CNFR Conifer Holdings Inc.
Conifer Holdings Inc is an insurance company engaged in the sale of property and casualty insurance products. It is engaged in three classes of insurance businesses namely commercial lines, personal lines, and wholesale agency business. Within these three businesses, the company offers various insurance products and insurance agency services. The company views the commercial and personal lines segments as underwriting business. The wholesale agency business provides non-risk bearing revenue through commissions and policy fees. Its revenues are derived from premiums earned from insurance operations.
About HOTH Hoth Therapeutics Inc.
Hoth Therapeutics Inc is a development-stage biopharmaceutical company. It is focused on targeted therapeutics for patients suffering from conditions such as atopic dermatitis, also known as eczema, chronic wounds, psoriasis, asthma, and acne. The company owns the BioLexa Platform which combines an FDA-approved zinc chelator with one or more approved antibiotics in a topical dosage form to address unchecked eczema flare-ups.